Browsing Tag
United Therapeutics Corporation
2 posts
Could engineered pig hearts become the next major frontier in biotechnology investing?
Find out how United Therapeutics’ FDA-cleared UHeart trial could reshape engineered organ transplants and investor expectations.
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
United Therapeutics reports strong Phase 3 TETON-2 results for Tyvaso in idiopathic pulmonary fibrosis. Discover why this inhaled therapy could reshape treatment.